Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics

World Journal of Biological Psychiatry

Volumn 18, Issue 7, 2017, Pages 492-505

  Giegling, Ina ^a,b   Hosak, Ladislav ^c   Mössner, Rainald ^d   Serretti, Alessandro ^e   Bellivier, Frank ^f,g   Claes, Stephan ^h,i   Collier, David A ^j,k   Corrales, Alejo ^l   DeLisi, Lynn E ^m,n   Gallo, Carla ^o   Gill, Michael ^p   Kennedy, James L ^q,r,s   Leboyer, Marion ^t,u,v,w   Maier, Wolfgang ^x   Marquez, Miguel ^y   Massat, Isabelle ^z,aa   Mors, Ole ^ab,ac   Muglia, Pierandrea ^ad   Nöthen, Markus M ^x,ae   Ospina Duque, Jorge ^af   Owen, Michael J ^ag   Propping, Peter ^x   Shi, YongYong ^ah,ai   St Clair, David ^aj   Thibaut, Florence ^ak   Cichon, Sven ^x,ae,al,am   Mendlewicz, Julien ^z   O'Donovan, Michael C ^ag   Rujescu, Dan ^a,b   more..

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f SAINT LOUIS HOSPITAL   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k ELI LILLY AND COMPANY   (United States)

^l UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^m Clinical Neuroscience Division   (United States)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

^o UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^p TRINITY COLLEGE DUBLIN   (Ireland)

^q CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^r UNIVERSITY OF TORONTO   (Canada)

^s UNIVERSITY OF TORONTO   (Canada)

^t FACULTÉ DE MÉDECINE   (France)

^u HENRI MONDOR HOSPITAL   (France)

^v Hopital Albert Chenevier   (France)

^w FONDATION FONDAMENTAL   (France)

^x UNIVERSITY OF BONN   (Germany)

^y Asistencia   (Argentina)

^z UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^aa FNRS   (Belgium)

^ab AARHUS UNIVERSITY HOSPITAL   (Denmark)

^ac Lundbeck Foundation Initiative for Integrative Psychiatric Research   (Denmark)

^ad UCB PHARMA   (Belgium)

^ae Life and Brain Center   (Germany)

^af UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^ag CARDIFF UNIVERSITY   (United Kingdom)

^ah SHANGHAI JIAO TONG UNIVERSITY   (China)

^ai QINGDAO UNIVERSITY   (China)

^aj UNIVERSITY OF ABERDEEN   (United Kingdom)

^ak The Affiliated Hospital of Qingdao University ^*  (France)

^al UNIVERSITY OF BASEL   (Switzerland)

^am FORSCHUNGSZENTRUM JÜLICH   (Germany)

more..

Author keywords

genetic; Genetics; genome; polygenic; psychiatry; psychosis; schizophrenia; sequencing

Indexed keywords

CONSENSUS; COPY NUMBER VARIATION; GENE DELETION; GENE DUPLICATION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; MULTIFACTORIAL INHERITANCE; NEXT GENERATION SEQUENCING; NONHUMAN; PATHOGENESIS; REVIEW; SCHIZOPHRENIA; GENETICS;

CONSENSUS; HUMANS; SCHIZOPHRENIA;

EID: 85010686603     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622975.2016.1268715     Document Type: Review

References (112)

1. Abdelmoity AT, LePichon J-B, Nyp SS, Soden SE, Daniel CA, Yu S., 2012. 15q11.2 proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features. J Dev Behav Pediatr. 33:570–576.
2. Adams CE, Yonchek JC, Schulz KM, Graw SL, Stitzel J, Teschke PU, Stevens KE., 2012. Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function:implications for neuropsychiatric diseases. Neuroscience. 207:274–282.
3. Agerbo E, Sullivan PF, Vilhjálmsson BJ, Pedersen CB, Mors O, Børglum AD, Hougaard DM, Hollegaard MV, Meier S, Mattheisen M, et al. 2015. Polygenic risk score, parental socioeconomic status, family history of psychiatric disorders, and the risk for schizophrenia:a Danish population-based study and meta-analysis. JAMA Psychiatry. 72:635–641.
4. Akbarian S., 2014. Epigenetic mechanisms in schizophrenia. Dialogues Clin Neurosci. 16:405–417.
5. Bassett AS, McGillivray BC, Jones BD, Pantzar JT., 1988. Partial trisomy chromosome 5 cosegregating with schizophrenia. Lancet. 1:799–801.
6. Beards S, Gayer-Anderson C, Borges S, Dewey ME, Fisher HL, Morgan C., 2013. Life events and psychosis:a review and meta-analysis. Schizophr Bull. 39:740–747.
7. Cardno AG, Gottesman II., 2000. Twin studies of schizophrenia:from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet. 97:12–17.
8. CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium, Psychosis Endophenotypes International Consortium. 2016. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. doi:10.1038/ng.3725 [Epub ahead of print].
9. de Kovel CG, Trucks H, Helbig I, Mefford HC, Baker C, Leu C, Kluck C, Muhle H, von Spiczak S, Ostertag P, et al. 2010. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain. 133:23–32.
10. Derks EM, Ayub M, Chambert K, Del Favero J, Johnstone M, MacGregor S, Maclean A, McKechanie AG, McRae AF, Moran JL, et al. 2013. A genome wide survey supports the involvement of large copy number variants in schizophrenia with and without intellectual disability. Am J Med Genet B Neuropsychiatr Genet. 162B:847–854.
11. EU-GEI. 2014. Identifying gene-environment interactions in schizophrenia:contemporary challenges for integrated, large-scale investigations. Schizophr Bull. 40:729–736.
12. Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, Loh PR, Anttila V, Xu H, Zang C, Farh K, et al. 2015. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet. 47:1228–1235.
13. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, Georgieva L, Rees E, Palta P, Ruderfer DM, et al. 2014. De novo mutations in schizophrenia implicate synaptic networks. Nature. 506:179–184.
14. Gatt JM, Burton KL, Williams LM, Schofield PR., 2015. Specific and common genes implicated across major mental disorders:a review of meta-analysis studies. J Psychiatr Res. 60:1–13.
15. Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S, Jouan L, Dionne-Laporte A, Spiegelman D, Henrion E, Diallo O, et al. 2011. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet. 43:860–863.
16. Gottesman II, Laursen TM, Bertelsen A, Mortensen PB., 2010. Severe mental disorders in offspring with 2 psychiatrically ill parents. Arch Gen Psychiatry. 67:252–257.
17. Grayton HM, Fernandes C, Rujescu D, Collier DA., 2012. Copy number variations in neurodevelopmental disorders. Prog Neurobiol. 99:81–91.
18. Grozeva D, Conrad DF, Barnes CP, Hurles M, Owen MJ, O'Donovan MC, Craddock N, Kirov G, WTCCC. 2012. Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophr Res. 135:1–7.
19. Guha S, Rees E, Darvasi A, Ivanov D, Ikeda M, Bergen SE, Magnusson PK, Cormican P, Morris D, Gill M, Molecular Genetics of Schizophrenia Consortium; Wellcome Trust Case Control Consortium 2, et al. 2013. Implication of a rare deletion at distal 16p11.2 in schizophrenia. JAMA Psychiatry. 70:253–260.
20. Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, Rippey C, Shahin H, Consortium on the Genetics of Schizophrenia (COGS); PAARTNERS Study Group, Nimgaonkar VL, Go RC, Savage RM, Swerdlow NR, Gur RE, Braff DL, King MC, McClellan JM, et al. 2013. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell. 154:518–529.
21. Gusev A, Lee SH, Trynka G, Finucane H, Vilhjálmsson BJ, Xu H, Zang C, Ripke S, Bulik-Sullivan B, Stahl E, Schizophrenia Working Group of the Psychiatric Genomics Consortium; SWE-SCZ Consortium, et al. 2014. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am J Hum Genet. 95:535–552.
22. Haldeman-Englert CR, Jewett T., 1993–2016. 1q21.1 Recurrent Microdeletion. In Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. Seattle, WA:GeneReviews(R).
23. Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D, Jones I, Forty L, Jones L, Gordon-Smith K, et al. 2013. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry. 18:708–712.
24. Helbig I, Mefford HC, Sharp AJ, Guipponi M, Fichera M, Franke A, Muhle H, de Kovel C, Baker C, von Spiczak S, et al. 2009. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet. 41:160–162.
25. Ingason A, Kirov G, Giegling I, Hansen T, Isles AR, Jakobsen KD, Kristinsson KT, le Roux L, Gustafsson O, Craddock N, et al. 2011a. Maternally derived microduplications at 15q11-q13:implication of imprinted genes in psychotic illness. Am J Psychiatry. 168:408–417.
26. Ingason A, Rujescu D, Cichon S, Sigurdsson E, Sigmundsson T, Pietiläinen OP, Buizer-Voskamp JE, Strengman E, Francks C, Muglia P, et al. 2011b. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry. 16:17–25.
27. International Schizophrenia Consortium. 2008. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 455:237–241.
28. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P., 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 460:748–752.
29. Irish Schizophrenia Genomics Consortium and the Wellcome Trust Case Control Consortium 2. 2012. Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol Psychiatry. 72:620–628.
30. Isles AR, Ingason A, Lowther C, Walters J, Gawlick M, Stöber G, Rees E, Martin J, Little RB, Potter H, et al. 2016. Parental origin of interstitial duplications at 15q11.2-q13.3 in schizophrenia and neurodevelopmental disorders. PLoS Genet. 12:e1005993.
31. Jaffee SR, Price TS., 2007. Gene-environment correlations:a review of the evidence and implications for prevention of mental illness. Mol Psychiatry. 12:432–442.
32. Jenkins AK, Paterson C, Wang Y, Hyde TM, Kleinman JE, Law AJ., 2016. Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging. Mol Psychiatry. 21:701–706.
33. Kendler KSA., 2015. Joint history of the nature of genetic variation and the nature of schizophrenia. Mol Psychiatry. 20:77–83.
34. Kennedy JL, Giuffra LA, Moises HW, Cavalli-Sforza LL, Pakstis AJ, Kidd JR, Castiglione CM, Sjogren B, Wetterberg L, Kidd KK., 1988. Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature. 336:167–170.
35. Kirov G, Gumus D, Chen W, Norton N, Georgieva L, Sari M, O'Donovan MC, Erdogan F, Owen MJ, Ropers HH, et al. 2008. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet. 17:458–465.
36. Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, Holmans P, International Schizophrenia Consortium; Wellcome Trust Case Control Consortium, Craddock N, Owen MJ, O'Donovan MC., 2009a. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 18:1497–1503.
37. Kirov G, Rujescu D, Ingason A, Collier DA, O'Donovan MC, Owen MJ., 2009b. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull. 35:851–854.
38. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D, Moran J, Chambert K, Toncheva D, Georgieva L, et al. 2012. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry. 17:142–153.
39. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane JM, Kucherlapati R, Malhotra AK., 2007. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry. 12:572–580.
40. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J, Zhang N, Mowry BJ, Olincy A, Amin F, et al. 2011. Copy number variants in schizophrenia:confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry. 168:302–316.
41. Lichtenstein P, Björk C, Hultman CM, Scolnick E, Sklar P, Sullivan PF., 2006. Recurrence risks for schizophrenia in a Swedish national cohort. Psychol Med. 36:1417–1425.
42. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM., 2009. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families:a population-based study. Lancet. 373:234–239.
43. Malhotra D, Sebat J., 2012. CNVs:harbingers of a rare variant revolution in psychiatric genetics. Cell. 148:1223–1241.
44. Maric NP, Svrakic DM., 2012. Why schizophrenia genetics needs epigenetics:a review. Psychiatr Danub. 24:2–18.
45. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M, Moessner R, Pinto D, Ren Y, et al. 2008. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 82:477–488.
46. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S, Perkins DO, Dickel DE, Kusenda M, Krastoshevsky O, et al. 2009. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet. 41:1223–1227.
47. McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y, Mistry M, Pavlidis P, Solomon R, Ghiban E, et al. 2014. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry. 19:652–658.
48. Millar JK, Christie S, Semple CA, Porteous DJ., 2000. Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia. Genomics. 67:69–77.
49. Miller BJ, Culpepper N, Rapaport MH, Buckley P., 2013. Prenatal inflammation and neurodevelopment in schizophrenia:a review of human studies. Prog Neuropsychopharmacol Biol Psychiatry. 42:92–100.
50. Modinos G, Iyegbe C, Prata D, Rivera M, Kempton MJ, Valmaggia LR, et al. 2013. Molecular genetic gene-environment studies using candidate genes in schizophrenia:A systematic review. Schizophr Res. 150:356–365.
51. Moffitt TE, Caspi A, Rutter M., 2005. Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry. 62:473–481.
52. Moreno-De-Luca D, Mulle JG, Kaminsky EB, Sanders SJ, GeneSTAR, Myers SM, Adam MP, Pakula AT, Eisenhauer NJ, Uhas K, SGENE Consortium, et al. 2010. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet. 87:618–630.
53. Muir WJ, Pickard BS, Blackwood DH., 2008. Disrupted-in-Schizophrenia-1. Curr Psychiatry Rep. 10:140–147.
54. Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC, Sobreira NL, Valle D, Rudd MK, Satten G, et al. 2010. Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet. 87:229–236.
55. Mulle JG, Pulver AE, McGrath JA, Wolyniec PS, Dodd AF, Cutler DJ, Sebat J, Malhotra D, Nestadt G, Conrad DF, et al. 2014. Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biol Psychiatry. 75:371–377.
56. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H., 1986. Specific enzymatic amplification of DNA in vitro:the polymerase chain reaction. Cold Spring Harb Symp Quant Biol. 51(Pt 1):263–273.
57. Mullis KB, Ferré F, Gibbs RA., 1994.The polymerase chain reaction. Basel, Berlin, Boston:Birkhäuser.
58. NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, et al. 2007. Replicating genotype-phenotype associations. Nature. 447:655–660.
59. Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, Arinami T, Riley B, Paunio T, Pulver AE, Irmansyah, et al. 2009. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry. 14:774–785.
60. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, et al. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 40:1053–1055.
61. Owen MJ, Sawa A, Mortensen PB., 2016. Schizophrenia. Lancet. S0140-6736:01121–01126.
62. Pagnamenta AT, Wing K, Sadighi Akha E, Knight SJ, Bölte S, Schmötzer G, Duketis E, Poustka F, Klauck SM, Poustka A, International Molecular Genetic Study of Autism Consortium, et al. 2009. A 15q13.3 microdeletion segregating with autism. Eur J Hum Genet. 17:687–692.
63. Pelayo-Teran JM, Suarez-Pinilla P, Chadi N, Crespo-Facorro B., 2012. Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis. Curr Pharmaceutic Design. 18:5024–5035.
64. Perkins DO, Jeffries C, Sullivan P., 2005. Expanding the 'central dogma':the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia. Mol Psychiatry. 10:69–78.
65. Pocklington AJ, Rees E, Walters JT, Han J, Kavanagh DH, Chambert KD, Holmans P, Moran JL, McCarroll SA, Kirov G, et al. 2015. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron. 86:1203–1214.
66. Porteous DJ, Thomson PA, Millar JK, Evans KL, Hennah W, Soares DC, McCarthy S, McCombie WR, Clapcote SJ, Korth C, et al. 2014. DISC1 as a genetic risk factor for schizophrenia and related major mental illness:response to Sullivan. Mol Psychiatry. 19:141–143.
67. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, Morrow B, Karayiorgou M, Antonarakis SE, Housman D, et al. 1994. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis. 182:476–478.
68. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O'Dushlaine C, Chambert K, Bergen SE, Kähler A, et al. 2014. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 506:185–190.
69. Randall AD, Kurihara M, Brandon NJ, Brown JT., 2014. Disrupted in schizophrenia 1 and synaptic function in the mammalian central nervous system. Eur J Neurosci. 39:1068–1073.
70. Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, Fantini C, Brévière GM, Di Rosa G, Pustorino G, et al. 2007. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet. 16:83–91.
71. Rees E, Walters JT, Georgieva L, Isles AR, Chambert KD, Richards AL, Mahoney-Davies G, Legge SE, Moran JL, McCarroll SA, et al. 2014. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry. 204:108–114.
72. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S, Bergen SE, Collins AL, Crowley JJ, Fromer M, et al. 2013. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 45:1150–1159.
73. Rujescu D, Ingason A, Cichon S, Pietiläinen OP, Barnes MR, Toulopoulou T, Picchioni M, Vassos E, Ettinger U, Bramon E, et al. 2009. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet. 18:988–996.
74. Rutter M, Moffitt TE, Caspi A., 2006. Gene-environment interplay and psychopathology:multiple varieties but real effects. J Child Psychol Psychiatry. 47:226–261.
75. Sanders SJ, He X, Willsey AJ, Ercan-Sencicek AG, Samocha KE, Cicek AE, Murtha MT, Bal VH, Bishop SL, Dong S, et al. 2015. Insights into autism spectrum disorder genomic architecture and biology from 71 Risk Loci. Neuron. 87:1215–1233.
76. Schaaf CP, Boone PM, Sampath S, Williams C, Bader PI, Mueller JM, Shchelochkov OA, Brown CW, Crawford HP, Phalen JA, et al. 2012. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions. Eur J Hum Genet. 20:1240–1247.
77. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 43:969–976.
78. Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 511:421–427.
79. Schmitt A, Rujescu D, Gawlik M, Hasan A, Hashimoto K, Iceta S, Jarema M, Kambeitz J, Kasper S, Keeser D, WFSBP Task Force on Biological Markers, et al. 2016. Consensus paper of the WFSBP task force on biological markers:criteria for biomarkers and endophenotypes of schizophrenia part II:cognition, neuroimaging and genetics. World J Biol Psychiatry. 17:406–428.
80. Schneider M, Debbané M, Bassett AS, Chow EW, Fung WL, van den Bree M, Owen M, Murphy KC, Niarchou M, Kates WR, International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome, et al. 2014. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome:results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 171:627–639.
81. Shih RA, Belmonte PL, Zandi PP., 2004. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. IntRev Psychiatry. 16:260–283.
82. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, et al. 2016. Schizophrenia risk from complex variation of complement component 4. Nature. 530:177–183.
83. Sherrington R, Brynjolfsson J, Petursson H, Potter M, Dudleston K, Barraclough B, Wasmuth J, Dobbs M, Gurling H., 1988. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature. 336:164–167.
84. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, et al. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 460:753–757.
85. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW., 1992. Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet. 42:141–142.
86. Singh T, Kurki MI, Curtis D, Purcell SM, Crooks L, McRae J, Suvisaari J, Chheda H, Blackwood D, Breen G, et al. 2016. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat Neurosci. 19:571–577.
87. Squarcione C, Torti MC, Di Fabio F, Biondi M., 2013. 22q11 deletion syndrome:a review of the neuropsychiatric features and their neurobiological basis. Neuropsychiatr Dis Treat. 9:1873–1884.
88. St Clair D, Blackwood D, Muir W, Baillie D, Hubbard A, Wright A, Evans HJ., 1989. No linkage of chromosome 5q11-q13 markers to schizophrenia in Scottish families. Nature. 339:305–309.
89. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C, Evans HJ., 1990. Association within a family of a balanced autosomal translocation with major mental illness. Lancet. 336:13–16.
90. Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, et al. 2008. Large recurrent microdeletions associated with schizophrenia. Nature. 455:232–236.
91. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietiläinen OP, Mors O, Mortensen PB, et al. 2009. Common variants conferring risk of schizophrenia. Nature. 460:744–747.
92. Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S, Pietiläinen OP, Lin K, Papiol S, Huttenlocher J, et al. 2014. Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry. 19:108–114.
93. Sullivan PF, Kendler KS, Neale MC., 2003. Schizophrenia as a complex trait:evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 60:1187–1192.
94. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, et al. 2008. Genomewide association for schizophrenia in the CATIE study:results of stage 1. Mol Psychiatry. 13:570–584.
95. Svrakic DM, Zorumski CF, Svrakic NM, Zwir I, Cloninger CR., 2013. Risk architecture of schizophrenia:the role of epigenetics. Curr Opin Psychiatry. 26:188–195.
96. Szyf M., 2015. Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications. Eur Neuropsychopharmacol. 25:682–702.
97. Uher R., 2014. Gene-environment interactions in severe mental illness. Front Psychiatry. 5:48
98. van Dongen J, Boomsma DI., 2013. The evolutionary paradox and the missing heritability of schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 162B:122–136.
99. van Os J, Rutten BPF., 2009. Gene-environment-wide interaction studies in psychiatry. Am J Psychiatry. 166:964–966.
100. van Os J, Rutten BPF, Poulton R., 2008. Gene-environment interactions in schizophrenia:review of epidemiological findings and future directions. Schizophr Bull. 34:1066–1082.
101. van Winkel R, Stefanis NC, Myin-Germeys I., 2008. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull. 34:1095–1105.
102. Vacic V, McCarthy S, Malhotra D, Murray F, Chou HH, Peoples A, Makarov V, Yoon S, Bhandari A, Corominas R, et al. 2011. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature. 471:499–503.
103. Vieland VJ, Walters KA, Lehner T, Azaro M, Tobin K, Huang Y, Brzustowicz LM., 2014. Revisiting schizophrenia linkage data in the NIMH Repository:reanalysis of regularized data across multiple studies. Am J Psychiatry. 171:350–359.
104. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 320:539–543.
105. Waterland RA, Jirtle RL., 2003. Transposable elements:targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol. 23:5293–5300.
106. Williams NM, Franke B, Mick E, Anney RJ, Freitag CM, Gill M, Thapar A, O’Donovan MC, Owen MJ, Holmans P, et al. 2012. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder:the role of rare variants and duplications at 15q13.3. Am J Psychiatry. 169:195–204.
107. Wong AH, Gottesman II, Petronis A., 2005. Phenotypic differences in genetically identical organisms:the epigenetic perspective. Hum Mol Genet. 14:R11–18.
108. Wray NR, Gottesman II., 2012. Using summary data from the danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front Genet. 3:118.
109. Wray NR, Lee SH, Mehta D, Vinkhuyzen AA, Dudbridge F, Middeldorp CM., 2014. Research review:polygenic methods and their application to psychiatric traits. J Child Psychol Psychiatry. 55:1068–1087.
110. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M., 2008. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet. 40:880–885.
111. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M., 2011. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet. 43:864–868.
112. Xu B, Ionita-Laza I, Roos JL, Boone B, Woodrick S, Sun Y, Levy S, Gogos JA, Karayiorgou M., 2012. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet. 44:1365–1369.